TrialThe Lancet. Infectious diseases2023

Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.

Amanda L Wilkinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.